Stay updated with breaking news from Chemo Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SAINT LAURENT, Quebec, May 11, 2023 -- IntelGenx Technologies Corp. today reported financial results for the first quarter ended March 31, 2023. All dollar amounts are expressed in... | May 11, 2023
By Robb M. Stewart IntelGenx Corp.'s shares jumped Thursday after the Canadian drug-delivery company and its partner received the U.S. Food and Drug Administration's review of the data... | April 27, 2023
By Robb M. Stewart IntelGenx Corp. said Thursday its partner will address concerns this quarter being raised by the U.S. Food and Drug Administration in a complete response letter to an... | April 27, 2023
SAINT LAURENT, Quebec, April 13, 2023 -- IntelGenx Technologies Corp. today announced various changes to its management team. Following the planned retirement of its founder and CEO, Horst... | April 13, 2023
To assess the effects that failure to take pills has on the efficacy of combined oral contraceptives, the researchers reviewed data from a pair of parallel phase 3 trials.